| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BAUSCH HEALTH COMPANIES | 2017-03 | PURCHASE | 2024-03 | 916 | 1,061 | -145 | ||||
| ALIBABA GROUP | 2017-03 | PURCHASE | 2023-08 | 1,806 | 1,858 | -52 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ALIBABA GROUP HOLDING | 5,760 | 5,760 |
| BEST INCORPORATED | 165 | 165 |
| BAUSCH HEALTH | 2,788 | 2,788 |
| Description | Amount |
|---|---|
| LOSS IN FMV | 1,282 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK CHARGES | ||||
| MISC EXP |
| Description | Amount |
|---|---|
| DIFF IN FMV/COST OF ASSETS SOLD | 451 |